Pulse Biosciences, Inc. is one of 5511 FDA 510(k) medical device manufacturers from United States in the dataset, ranked by real submission volume.
Pulse Biosciences, Inc. - FDA 510(k) Cleared Devices
Recent clearances: CellFX Percutaneous Electrode System (SYS3000), CellFX Percutaneous Electrode System (SYS3000), CellFX System
7
Total
7
Cleared
0
Denied
Pulse Biosciences, Inc. has 7 FDA 510(k) cleared medical devices. Based in Hayward, US.
Latest FDA clearance: Aug 2024. Active since 2021. Primary specialty: General & Plastic Surgery.
Browse the FDA 510(k) cleared devices submitted by Pulse Biosciences, Inc. Filter by specialty or product code using the sidebar.
FDA 510(k) Regulatory Record - Pulse Biosciences, Inc.
7 devices
Cleared
Aug 05, 2024
CellFX Percutaneous Electrode System (SYS3000)
General & Plastic Surgery
137d
Cleared
Mar 08, 2024
CellFX Percutaneous Electrode System (SYS3000)
General & Plastic Surgery
109d
Cleared
Sep 22, 2022
CellFX System
General & Plastic Surgery
304d
Cleared
Sep 02, 2022
CellFX System
General & Plastic Surgery
50d
Cleared
Aug 01, 2022
CellFX® System
General & Plastic Surgery
53d
Cleared
Aug 25, 2021
CellFX System
General & Plastic Surgery
107d
Cleared
Feb 02, 2021
CellFX System
General & Plastic Surgery
85d